Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations
Clinical trial NCT07566195 · RECRUITING
Trial details
- NCT number
- NCT07566195
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-05
- Primary completion
- 2028-12-29
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.